Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Aldeyra Therapeutics Inc ALDX

Healthcare Biotechnology
Aldeyra Therapeutics, Inc. is a biotechnology company, which is engaged in discovering therapies designed to treat immune-mediated diseases. The Company's product candidates include reactive aldehyde species (RASP) modulators ADX-629, ADX-246, ADX-248, and chemically related molecules for the treatment of systemic and retinal immune-mediated diseases. Its pre-commercial product candidates are... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ALDX)

Aldeyra Therapeutics to Host Research & Development Day on April 25, 2024

Business Wire 6 days ago

Attention Long-Term Aldeyra Therapeutics, Inc. (ALDX) Investors: Grabar Law Office Is Investigating Claims on Your Behalf

Newsfile 10 days ago

Attention Long-Term Aldeyra Therapeutics, Inc. (ALDX) Investors

Newsfile March 29, 2024

Aldeyra Therapeutics Announces Clinical Development Plan for Resubmission of New Drug Application for Reproxalap in Dry Eye Disease

Business Wire March 28, 2024

Notice to Long-Term Aldeyra Therapeutics, Inc. (ALDX) Investors

Newsfile March 27, 2024

Grabar Law Office Investigates Claims on Behalf of Shareholders of Aldeyra Therapeutics, Inc. (ALDX)

Newsfile March 20, 2024

Aldeyra Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Business Wire February 6, 2024

Grabar Law Office Investigates Claims on Behalf of Shareholders of Aldeyra Therapeutics, Inc. (ALDX)

Newsfile January 12, 2024

Grabar Law Office Investigates Claims on Behalf of Shareholders of Aldeyra Therapeutics, Inc. (ALDX)

Newsfile January 8, 2024
View More News ››

Opinion & Analysis (NDAQ:ALDX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ALDX)

ALDX.....LoL....even The Pumpers are pumping their book

on this "Train Wreck" Sheesh
Iseneschal - October 16, 2023

WILL ALDEYRA HIT THE BULL’S EYE IN DRY EYE?

$ALDX    Excited to share our latest coverage on Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) which announced positive...
AviseAnalytics - July 19, 2022

it's a buy today for me

missed the bottom,but it is way oversold,so paid $5.76 per share and looking for a quick rebound of this one glta shareholders.
coolfooldumbguy - June 25, 2019

positive results

we will see what happens in April with this stock,so glta.
coolfooldumbguy - March 31, 2019

RE:watching this one for

Maybe i should of waited too. Dont understand why it didnt go up higher and why its giving back all its gains
Torontoinvestor - March 28, 2019

watching this one for

some time,but it broke out big time this morning,but will not chase it as my watchlist is full of stocks.
coolfooldumbguy - March 26, 2019
View more Bullboard ››

Voyageur Pharmaceuticals Ltd

Voyageur Pharmaceuticals Ltd

Voyageur Pharmaceuticals Ltd. is a Canadian company, which develops barium, iodine and carbon active pharmaceutical ...
View More »